
Eltoplate 25mg Tablet
Salt Composition: Eltrombopag Olamine
Expiry Date: 01/2028
Inclusive of all taxes
7 Tablets in a Strip
About The Product
Hepatitis C, Hepatitis Medicines, Low Red Platelet Count
Description
Eltoplate 25mg Tablet is prescribed by the doctor to treat low platelet counts in specific blood-related conditions. It is mainly given in combination with other medicines to treat a particular condition or increase effectiveness.
Eltoplate 25mg Tablet contains Eltrombopag Olamine that promotes the proliferation and differentiation of megakaryocytes, leading to increased platelet formation and reduced bleeding risk in conditions like chronic ITP, hepatitis C-related thrombocytopenia, or severe aplastic anemia.
Common Side Effects
- Eltoplate 25mg Tablet can cause multiple side effects, most of which are mild to moderate and often temporary.
- Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time. ● Headache ● Nausea ● Tiredness ● Diarrhea ● Insomnia ● Dizziness ● Loss of Appetite ● Rashes ● Muscle Pain ● Fever ● Chills ● Allergic Reaction ● Liver Problem ● Blood Clots ● Allergic Reaction
Dosage And Administration
- The usual dose of Eltoplate 25mg Tablet is one tablet daily.
- It should be taken on an empty stomach, at the same time each day for consistent blood levels.
- Consult your doctor for individual dosage as it may vary person to person based on its stage and overall health.Tablet is taken orally with the help of water.
- Avoid breaking, chewing, biting and crushing of tablet to maintain the medication efficacy.
Mechanism Of Action
Eltoplate 25mg Tablet contains Eltrombopag Olamine, Eltrombopag binds to and activates the transmembrane domain of the TPO receptor (c-Mpl) on megakaryocyte progenitors in the bone marrow, triggering signaling pathways.
This promotes the proliferation and differentiation of megakaryocytes, leading to increased platelet formation and reduced bleeding risk in conditions like chronic ITP, hepatitis C-related thrombocytopenia, or severe aplastic anemia.
Safety Advice
Faqs
Eltoplate 25mg Tablet is used to treat low platelet counts in specific blood-related conditions.
References
• Garnock-Jones, K. P., & Keam, S.
J. (2009).
Eltrombopag. Drugs, 69(5), 567-576. • Gonzalez-Porras, J.
R., & Bastida, J. M.
(2018). Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.
Therapeutic advances in drug safety, 9(6), 263-285. • Lozano, M. L., Segú-Vergés, C., Coma, M., Álvarez-Roman, M.
T., González-Porras, J. R., Gutiérrez, L., ... & Butta, N.
(2021). Elucidating the mechanism of action of the attributed immunomodulatory role of eltrombopag in primary immune thrombocytopenia: an in silico approach.
International journal of molecular sciences, 22(13), 6907. • Raslova, H., Vainchenker, W., & Plo, I. (2016).
Eltrombopag, a potent stimulator of megakaryopoiesis. Haematologica, 101(12), 1443.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
